Qarziba

Dinutuximab beta · Recordati Netherlands B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Qarziba, covering 2025-11-26 to 2025-11-26. Get the full timeline:

Most recent: EMA Authorised: Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) (Dinutuximab beta) — Recordati Netherlands B.V.